Drug Profile
Ciclosporin ophthalmic - Altacor
Alternative Names: Cyclosporin A - OphthalmoPharma; Cyclosporin A prodrug - OphthalmoPharma; OPPH 088Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator CIS Pharma
- Developer Altacor
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dry eyes; Keratoplasty rejection; Uveitis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Dry-eyes in England (Ophthalmic)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Keratoplasty-rejection(Prevention) in England (Ophthalmic)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Uveitis in England (Ophthalmic)